MeeraBChitlurMD

Pediatric Hematology & Oncology • Detroit, MI

Pediatric Coagulation Disorder Hematology

Professor, Pediatrics, Wayne State University School of Medicine

Join to view full profile

Dr. Chitlur is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Chitlur's full profile

Already have an account?

Office
3901 Beaubien St
Detroit, MI 48201
Phone+1 313-745-5515

Fax+1 313-745-5432

Education & Training

Children's Hospital of MichiganFellowship, Pediatric Hematology/Oncology, 2001 - 2005
Henry Ford Hospital/Wayne State UniversityResidency, Pediatrics, 1994 - 1997
Kempegowda Institute of Medical ScienceClass of 1992

Certifications & Licensure

MI State Medical License 1997 - 2025
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

America’s best physician National Consumer Advisory Board, 2019-2023
Top Doc Hour Magazine, 2019-2022
Super Doctor SuperDoctors.com

Clinical Trials

Personalized Prediction of Tolerance and Immunogenicity in Hemophilia Start of enrollment: 2012 Jun 01
Unknown status

Publications & Presentations

PubMed

14 citations
Survey of laboratory tests used in the diagnosis and evaluation of haemophilia A
Keith Gomez, Meera Chitlur
Thrombosis and Haemostasis. 2013-01-31
104 citations
Inhibitors in factor IX deficiency a report of the ISTH-SSC international FIX inhibitor registry (1997-2006).
Meera Chitlur, Indira Warrier, Madhvi Rajpurkar, Jeanne M. Lusher
Haemophilia. 2009-09-01
8 citations
Severe neutropenia and thrombocytopenia following cardiac transplantation in a child.
Meera Chitlur, E. Abella, Tajinder P. Singh, Süreyya Savaşan
Pediatric Transplantation. 2005-02-01

Abstracts/Posters

On the Role of F8 Sequence Mismatch and Class-II Human Leukocyte Antigen Binding in the Development of Neutralizing Antibodies (Inhibitors) Directed Against Therapeuti...
Meera B. Chitlur, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

An Update on rFVIIa Use in Females with Rare Bleeding Disorders
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Genetics of Factor VIII Inhibitor Development in Hemophilia Patients: Novel Statistical Approaches in the PATH Study
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Efficacy of an Extended Half-Life GlycoPEGylated rFVIII (N8-GP): Pooled Analysis of ABR (Results from Two Clinical Trials)
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018